This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.
The full functionality of our site is not supported on your browser version, or you may have 'compatibility mode' selected. Please turn off compatibility mode, upgrade your browser to at least Internet Explorer 9, or try using another browser such as Google Chrome or Mozilla Firefox.

ESMA expands Q&A document on the implementation of its APM guidance

  • ESMA (European Securities and Markets Authority) (dark gray) Image
  • covid1 Image

17 Apr 2020

In June 2015, the European Securities and Markets Authority (ESMA) published its final Guidelines on Alternative Performance Measures (APMs) for listed issuers that became effective in July 2016. Since then, ESMA has published several questions and answers on the guidelines to promote common supervisory approaches and practices in the implementation of them. A new question has now been added to the document on the use of APMs in the context of COVID-19.

The new question

  • highlights the main principles of the APM Guidelines;
  • encourages issuers to use caution when adjusting APMs and when including new APMs to address the impact of COVID-19; and
  • invites issuers to provide
    • narrative information regarding the modifications made, the assumptions used and the impact of COVID-19; and
    • information on measures taken or expected to be taken by issuers to address the impact that the COVID-19 outbreak may have in their operations and performance.

Please click to access the updated document on the ESMA website.

Correction list for hyphenation

These words serve as exceptions. Once entered, they are only hyphenated at the specified hyphenation points. Each word should be on a separate line.